Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $1.03 billion. The enterprise value is $864.42 million.
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 116.89 million shares outstanding. The number of shares has increased by 61.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 116.89M |
| Shares Change (YoY) | +61.61% |
| Shares Change (QoQ) | +11.20% |
| Owned by Insiders (%) | 2.07% |
| Owned by Institutions (%) | 86.32% |
| Float | 85.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.42 |
| Forward PS | 4.95 |
| PB Ratio | 5.45 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.46, with a Debt / Equity ratio of 1.11.
| Current Ratio | 8.46 |
| Quick Ratio | 7.90 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.94 |
Financial Efficiency
Return on equity (ROE) is -148.92% and return on invested capital (ROIC) is -33.11%.
| Return on Equity (ROE) | -148.92% |
| Return on Assets (ROA) | -29.36% |
| Return on Capital (ROIC) | -33.11% |
| Revenue Per Employee | $446,155 |
| Profits Per Employee | -$671,497 |
| Employee Count | 296 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, ARQT has paid $3.44 million in taxes.
| Income Tax | 3.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +260.92% in the last 52 weeks. The beta is 1.19, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +260.92% |
| 50-Day Moving Average | 9.69 |
| 200-Day Moving Average | 9.22 |
| Relative Strength Index (RSI) | 45.37 |
| Average Volume (20 Days) | 1,591,016 |
Short Selling Information
The latest short interest is 28.06 million, so 24.01% of the outstanding shares have been sold short.
| Short Interest | 28.06M |
| Short Previous Month | 27.13M |
| Short % of Shares Out | 24.01% |
| Short % of Float | 32.68% |
| Short Ratio (days to cover) | 14.47 |
Income Statement
In the last 12 months, ARQT had revenue of $132.06 million and -$198.76 million in losses. Loss per share was -$2.04.
| Revenue | 132.06M |
| Gross Profit | 121.91M |
| Operating Income | -179.77M |
| Pretax Income | -214.05M |
| Net Income | -198.76M |
| EBITDA | -178.29M |
| EBIT | -179.77M |
| Loss Per Share | -$2.04 |
Full Income StatementBalance Sheet
The company has $362.44 million in cash and $207.56 million in debt, giving a net cash position of $154.87 million or $1.32 per share.
| Cash & Cash Equivalents | 362.44M |
| Total Debt | 207.56M |
| Net Cash | 154.87M |
| Net Cash Per Share | $1.32 |
| Equity (Book Value) | 186.43M |
| Book Value Per Share | 1.60 |
| Working Capital | 383.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$176.95 million and capital expenditures -$70,000, giving a free cash flow of -$177.02 million.
| Operating Cash Flow | -176.95M |
| Capital Expenditures | -70,000 |
| Free Cash Flow | -177.02M |
| FCF Per Share | -$1.51 |
Full Cash Flow StatementMargins
Gross margin is 92.32%, with operating and profit margins of -136.13% and -150.51%.
| Gross Margin | 92.32% |
| Operating Margin | -136.13% |
| Pretax Margin | -147.90% |
| Profit Margin | -150.51% |
| EBITDA Margin | -135.01% |
| EBIT Margin | -136.13% |
| FCF Margin | -186.72% |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.61% |
| Shareholder Yield | -61.61% |
| Earnings Yield | -19.50% |
| FCF Yield | -17.37% |
Analyst Forecast
The average price target for ARQT is $14.40, which is 62.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.40 |
| Price Target Difference | 62.71% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 66.27% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of -1.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.88 |
| Piotroski F-Score | 4 |